Source: Eur Respir Monogr 2020; 88: 212-228
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Raúl Méndez, Paula González-Jiménez, Laura Feced, Enrique Zaldívar, Rosario Menéndez. Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections. Eur Respir Monogr 2020; 88: 212-228

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for pulmonary tuberculosis in community-acquired pneumonia Source: Eur Respir J 2014; 43: 1214 Year: 2014 Risk factors for pulmonary tuberculosis in community-acquired pneumonia Source: Eur Respir J 2014; 43: 1213 Year: 2014 Preventing community-acquired pneumonia Source: International Congress 2019 – Respiratory infections: prevention is better than cure Year: 2019 Epidemiology of community-acquired pneumonia and nosocomial pneumonia Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Severe community-acquired pneumonia Source: Eur Respir Monogr 2016; 74: 101-116 Year: 2016 Biomarkers and cardiovascular events in community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016 Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia Source: Annual Congress 2007 - Infections year in review Year: 2007 Etiology pathogens structure in community-acquired pneumonias and COPD exacerbations Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Lower respiratory tract infections: when are antibiotics mandatory? Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146 Year: 2004 Update on community-acquired pneumonia Source: International Congress 2017 – ME5 Update on community-acquired pneumonia Year: 2017 Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia Source: Annual Congress 2012 - CT findings: educational posters Year: 2012 Intrahospital cardiovascular complications in severe community-acquired pneumonia Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Clinical failure in community-acquired pneumonia Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases Year: 2014 Pulmonary sequelae of pneumonia Source: Annual Congress 2004 - PG18 - Childhood pneumonia after the turn of the new millennium Year: 2004 Prediction of in-hospital death from community-acquired pneumonia by varying CRB-age groups Source: Eur Respir J 2013; 41: 917-922 Year: 2013 Cardiovascular autonomic alterations and severity of the disease in community-acquired pneumonia Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 Nosocomial superinfection is one of the principal cause of mortality in severe community-acquired pneumonia Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Prevention of nosocomial infections in acute respiratory failure patients Source: Eur Respir J 2003; 22: 72S-76S Year: 2003 Update on preventing and managing hospital-acquired and ventilatory-associated pneumonia Source: International Congress 2019 – State of the art session: Respiratory infections Year: 2019